Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies
(Q80209074)
scientific article published on 01 September 2006
scientific article published on 01 September 2006
Language:
Current Data About
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies
other details
description | scientific article published on 01 September 2006 |
External Links
(P356) |
10.1158/1078-0432.CCR-06-0764
|
(P698) |
16951235
|